Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients

BACKGROUND: Carnitine deficiency may contribute to cardiovascular disease (CVD) in patients with hemodialysis (HD). Dyslipidemia plays a role in CVD and its prevalence is also high in HD patients. We examined here the effects of switching from oral administration (PO) to intravenous (IV) injection o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Kidney J
Autori principali: Fukami, Kei, Yamagishi, Sho-ichi, Sakai, Kazuko, Nasu, Makoto, Okuda, Seiya
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2014
Soggetti:
Original Contributions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379340/
https://ncbi.nlm.nih.gov/pubmed/25878778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfu082
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi